Behr, T M <br/><br/>
Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies.  [electronic resource] 

 -  Journal of nuclear medicine : official publication, Society of Nuclear Medicine  Mar 1997 
 - 409-18 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0161-5505 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--metabolism<br/>Aged<br/>Antibodies, Monoclonal--pharmacokinetics<br/>Carcinoembryonic Antigen--analysis<br/>Colorectal Neoplasms--metabolism<br/>Female<br/>Half-Life<br/>Humans<br/>Iodine Radioisotopes--therapeutic use<br/>Male<br/>Manganese--therapeutic use<br/>Middle Aged<br/>Mucins--metabolism<br/>Neptunium--therapeutic use<br/>Ovarian Neoplasms--metabolism<br/>Radioimmunotherapy<br/>Radioisotopes--therapeutic use<br/>Radiotherapy Dosage<br/>Thyroid Neoplasms--metabolism<br/>Tissue Distribution<br/>Tumor Cells, Cultured